Patienter med kronisk leversygdom (hepatocellulær, kolestatisk og biliær cirrhose) som fik en enkeltdosis cetirizin på 10 eller 20 mg, havde en 50% stigning i halveringstiden samt et fald på 40% i clearance sammenlignet med raske personer.
Patients with chronic liver diseases (hepatocellular, cholestatic, and biliary cirrhosis) given 10 or 20 mg of cetirizine as a single dose had a 50% increase in half-life along with a 40% decrease in clearance compared to healthy subjects.